During the past decade the mortality after pancreaticoduodenectomy decreased to 0-4% in centers with experience. The morbidity however remains high although a decrease has also been demonstrated. Leakage of the pancreatic anastomosis is the most severe complication associated with a high mortality reported between 8-40%. Resection of the pancreatic remnant is the most radical treatment but unfortunately associated with insulin dependent diabetes. Subtotal resection of the pancreas tail seems an alternative. The incidence of postoperative bleeding is decreasing in particular bleeding from ulcers. Bleeding from a pseudoaneurysm (2%) is leading to a high mortality up to 50% and early aggressive intervention is mandatory. Delayed gastric emptying is reported between 20-30%, the pathofysiology is still unknown but postoperative intra-abdominal complications proved to be a risk factor. It is now evident that mortality is strongly related with hospital experience and regionalization reduced overall mortality. These findings are arguments to favour centralization of surgery for biliopancreatic cancer.
Introduction Complications
The incidence of tumors in the pancreatic head region is currently around 10-15 per 100.000 in Europe. Despite improvement in the diagnosis and staging of pancreatic carcinoma, the prognosis did not change. It is one of the most lethal malignancies with a 5 years survival of 2-5 % [ 1 -2] . Because radical resection of the tumor is still the only hope for cure the partial pancreaticoduodenectomy as introduced by Kaush in 1912 or a modification of that procedure has been accepted as the treatment of choice for selected patients despite the high morbidity and mortality associated with resection [3, 4, 5] . In the earlier days many centers reported a mortality between 20% and 40%. During the past decade the mortality decreased dramatically and is currently between 0-4% in centers with experience [4] [5] [6] [7] [8] [9] . The operation is still associated with a high morbidity reported to be 30-52% and the complication rate is even high in series of more than 100 patients [6] [7] [8] [9] . In this review different aspects of the most common complications after pancreatic resection as well as mortality and correlation of mortality and center experience will be discussed. The complications after proximal bile duct resection with or without hemihepatectomy have been covered elsewhere.
The complication rate after pancreatic resection varies widely and is reported between 30-52% [6] [7] [8] [9] . This wide range is partly due to the fact that there is no uniformly accepted system to report or even to define complications. In some series the percentage of patients with one or more complication is reported while others reported the overall number of complications [10] [11] . The definition for example for leakage of the pancreatic anastomosis varies between clinical manifest leakage with severe disruption of the anastomosis found during relaparotomy versus limited prolonged drainage of amylase-rich fluid without any clinical signs of illness. Therefore complications should also be analysed in relation with the postoperative hospital stay and in hospital mortality. The most common complications are haemorrhage (3-16%), intra-abdominal abcesses (2-9%), leakage of the pancreaticojejunostomy (6-17%) leakage of the hepaticojejunostomy (3-9%) and delayed gastric emptying (20-30%). there was an important decrease in general cardiopulmonary complications partly due to improvement of patient selection but also due to improvement of intensive care management. In many studies correlation of complication rate and the time period investigated was reported. In a consecutive series of 312 patients who underwent a subtotal pancreaticoduodenectomy for a suspected malignancy of the pancreatic head region at the AMC the postoperative complications were analysed for three different time periods [7] . The total number of patients with complications decreased from 60% in the first period (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) to 41% in the last study period (1995) (1996) . The 41% overall postoperative complications in the last period are in accordance with findings from other high volume centers [6] [7] [8] [9] . Unfortunately no further decrease (complications: 43%) was found during the past 2 years in another 100 consecutive patients who underwent resection. The median hospital stay decreased from 24 days in the first period to 16 days in the last period and is currently 14 days. 39 (51) 11 (14) 1 (1) 7 (9) 24 (32) 17 (22) 211* 28.7 7-219
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Pancreatic leakage
Leakage of the pancreatic anastomosis is the most severe complication reported between 6-17%. In our series the incidence was 11 % and did not change significantly over the years [12] however it was 7% in the last 100 resections. It has been suggested that the incidence of leakage was related to the type of anastomosis for example, a pancreaticogastrostomy versus a pancreaticojejunostomy; the technique of the anastomosis, a duct to mucosa anastomosis versus an invaginating anastomosis or the use of additional technical possibilities as the use of a stapler for transection of the pancreas or occlusion of the pancreatic duct with fibrin glue or drainage catheters in the duct. Neither of these techniques reduced the leakage rate in a well conducted study [13, 14] except for the use of octreotide. Postoperative administration of octreotide reduced postoperative complications significantly in 4 randomized studies [15] [16] [17] [18] . Remarkably the fistula rate decreased in all studies after treatment with octreotide but the incidence of evidenced pancreatic anastomotic leakage was not affected. In a consecutive series of 269 patients who underwent pancreaticoduodenectomy at the AMC as well as in other studies the type of tumor (ampullary tumors), the pancreatic duct size, the degree of fibrosis of the pancreas and the experience of the surgeon could be identified as risk factors for leakage (6, 10, 11, 12) . Presently this anastomosis continues to be the menace of the operation. In our series postoperative leakage of the pancreaticojejunal anastomosis became evident after a median interval of 5 days. The most common clinical signs and findings from diagnostic procedures are summarized in table 3. Leakage of the anastomosis is associated with a high mortality reported between 8-40% (in our series 28%). In a retrospective study we analysed the outcome of treatment of anastomotic leakage and the effect of a change in treatment policy from drainage procedures toward early completion pancreatectomy [12, 19, 20] . The mortality in the drainage group (n=21) was 38% significantly higher compared with the resection group (n=8) 0%. The hospital stay was respectively 74 days versus 55 days. Unfortunately the last procedure is accompanied by insulin dependent diabetes. As an alternative a subtotal resection of the remnant of the pancreas was introduced recently and of the last 100 resections (mortality 1% and leakage 6%) subtotal resection had to be performed in 3 patients. None of these patients died and suffered from insulin dependent diabetes during follow up. One patient developed a pseudocyst at the pancreatic remnant and a cystogastrostomy had to be performed.
Haemorrhage
Postoperative gastrointestinal or intra-abdominal bleeding is another severe complication after resection of biliopancreatic tumors. In earlier studies gastrointestinal bleeding was reported up to 20% and mainly due to peptic ulcers. In more recent series haemorrhage is much less common and severe postoperative bleedings have been reported to originate mainly from the suture line of the intestinal anastomoses or from a false aneurysm of an eroded arterial stump that ruptures into the small intestine (for example the stump of the gastroduodenal artery) or from the mesenteric artery leading to an intra-abdominal bleeding. In a series of 686 patients who underwent major bilio-pancreatic surgery at our institution the incidence of massive postoperative bleeding (more than 6 units packed cells within 24 hours) was 3.2% [21] . Patients with pseudoaneurysm (arterial erosions) had a longer interval between surgery and bleeding ofter asso-ciated with sepsis and leakage of the anastomoses. This entity was associated with a high mortality (50%). Early aggressive diagnostic work up (arte-riography and endoscopy) and intervention by embolisation or surgery is indicated.
Delayed gastric emptying
Delayed gastric emptying (DGE) is another complication which prolongs hospital stay and might influence the "early" postoperative nutritional status and overall quality of life and gastrointestinal function. Some authors don't define delayed gastric emptying as a complication of the procedure but as "after-effect" or "sequelae" [4, 22, 23] . The complication occurs in 20-30% of the cases and variation of the incidence is partly due to the fact that no uniform definition exists. We defined DGE as nasogastric suction for 10 days or more or regular diet started after 14 days [22] DGE occured in 34% of the patients after the standard Whipple procedure and 37% of the patients after a PPPD. Several factors have been suggested to play a role in the pathofysiology of DGE from arterial supply of the pylorus, gastroduodenal neural connections, gastrointestinal hormones to the type of surgery performed. In our series the occurrence of intra-abdominal postoperative complications showed to be the only significant risk factor for delayed gastric emptying.
Mortality
It is evident that most results concerning mortality after resection are generally reported from centers with experience [4] [5] [6] [7] [8] [9] . These studies showed that mortality decreased significantly in the past decade and is currently between 0-4%. In our institution the mortality decreased from 4.9% in the period 1983-1992 (n=163) to 1.2% in 1993-1998 (n=250). In 1995 two studies from the USA have shown that mortality is directly related to the number of resections per year [24, 25] . In small volume centers the hospital mortality was higher compared to lower volume centers [24, 28] (table 4) . The higher mortality rate in low volume hospitals was leading to higher overall costs per patient compared with the (academic) high volume hospital [24] . Another study from New York demonstrated that mortality was in particular related to the number of resections in a center and not correlated to the surgeons individual experience suggesting that the role of the centre is important for the outcome [25] . In the Netherlands the mortality in small volume hospitals was 16% compared with 1.5% in high volume hospitals [26] . A recent study from Maryland showed that previous reports about mortality initiated regionalization of pancreato-duodenectomy. This was associated with a state wide reduction in mortality rate [28] . Unfortunately this phenomeon could not be demonstrated in the Netherlands. The overall mortality in 1996-1997 was still 10.7% and remained 16% in low volume hospitals. These findings are strong arguments to favour centralization of surgery for biliopancreatic cancer [24] [25] [26] [27] [28] .
